Today: 7 febrero 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-mavic-3t-pl- Page 177

Coca-Cola (KO) Stock: 7 Surprising Facts You Need to Know (Oct 11, 2025)

Coca-Cola Stock (KO) Today: Price, Fresh Analyst Calls and Key News on November 21, 2025

Published: November 21, 2025 – All figures as of market trading on this date. Coca-Cola stock today: near highs with fresh momentum Coca-Cola stock (NYSE: KO) is trading around $73 per share in Friday’s session, up roughly 2–2.5% from Thursday’s close of $71.21.StockAnalysis+1 That puts the beverage giant within touching distance of its 52‑week high of $74.38, and well above its 12‑month low of $60.62.StockAnalysis+1 Over the last year, Coca-Cola has delivered about 15% total shareholder return, including dividends, and is up just over 15% year to date, underscoring its role as a defensive winner in a choppy market.Simply Wall
21 noviembre 2025
·
Novo Nordisk Stock on 21 November 2025: NVO Slips as Denmark Grants Eye-Damage Payouts and GLP‑1 Price War Escalates

Novo Nordisk Stock on 21 November 2025: NVO Slips as Denmark Grants Eye-Damage Payouts and GLP‑1 Price War Escalates

Novo Nordisk stock is back in the spotlight today, 21 November 2025, as a cluster of breaking headlines hits the world’s most closely watched weight‑loss drug maker. As of late morning in New York, Novo Nordisk’s U.S. ADR (NYSE: NVO) is trading around $47.07, down roughly 1.1% on the day, giving the company a market value close to $213 billion. In Copenhagen, Novo Nordisk’s B‑shares finished the session around DKK 305, down nearly 3% and extending a steep slide that has left the stock down about 45% year‑to‑date. Investing.com+1 Today’s trading comes against a flurry of fresh news: Below is
21 noviembre 2025
···
NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know

NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know

NeuBase Therapeutics stock is one of those tickers that still pops up on certain quote screens in late 2025 – but in reality, it isn’t a “normal” stock anymore. As of Sunday, November 23, 2025, NeuBase is a dissolved biotech in legal wind‑down, its common shares delisted and largely cashed out through liquidation payments and a non‑tradable escrow structure. MarketWatch+1 Below is a deep, investor‑focused look at what NBSE actually represents today, what happened in 2024–2025, and what, if anything, existing shareholders can still reasonably expect. Key takeaways for NBSE on November 23, 2025 Where NeuBase stands today (Sunday, November
23 noviembre 2025
·
1 … 175 176 177

Stock Market Today

Salesforce stock tries to stabilize after AI “software-mageddon” — Feb. 25 earnings is the next test

Las acciones de Salesforce intentan estabilizarse tras el “software-magedón” de la IA: el próximo test serán los resultados del 25 de febrero

7 febrero 2026
Las acciones de Salesforce subieron un 0,1% a $190,07 el viernes tras una semana de caída del 9%. El sector software perdió $1 billón en valor desde el 28 de enero, y el índice S&P 500 de software y servicios bajó 4,6% el jueves. Salesforce presentará resultados el 25 de febrero. La presión proviene de la rápida integración de nuevas herramientas de IA como Claude Opus 4.6 de Anthropic.
Go toTop